Oncology

An expanding role for oncology pharmacy in the optimization of cancer care is likely to emerge over the next 3 to 5 years, as payers seek better outcomes for their money.

Both practice guidelines and thought leaders increasingly recommend biomarker tests for optimization of cancer care; there is, however, a gap between these recommendations, the way physicians practice, and the way they think they practice.